Finotonlimab
Finotonlimab (SCT-I10A) is a recombinant humanised IgG PD-1 antibody. Finotonlimab has the potential for solid tumors or lymphomas research[1].
Product Specifications
CAS Number
[2350298-85-8]
Product Name Alternative
SCT-I10A
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/finotonlimab.html
Purity
99.09
Solubility
10 mM in DMSO
Smiles
[Finotonlimab]
Molecular Weight
(145.38 kDa)
References & Citations
[1]Hiroshi Yano, et al. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity. Immunology. 2019 Jul;157 (3) :232-247.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99619/Finotonlimab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99619/Finotonlimab-SDS-MedChemExpress.pdf
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
N001-647-200UL 1x 200 µL
GFAP Recombinant Alpaca VHH (SdAb2409.GFAP), CF®647 Conjugate, MiniMabTM
Ask
View Details 
